Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

Bruno Mégarbane; Jean-Michel Scherrmann

首页> 外文期刊>The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology >Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

【24h】

Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

机译：羟基氯喹和阿奇霉素治疗Covid-19患者：两个朋友和敌人？

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The world is facing a frightening pandemic due to coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with thousands of severe infections and fatalities. Since no therapy has proven effective, an extraordinary race is taking place to identify an effective and safe treatment able to limit the disease progression and severity.

机译：由于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）引起的2019年冠状病毒病（COVID-19），世界正面临一场可怕的大流行，造成数千人严重感染和死亡。由于没有任何疗法被证明是有效的，一场非同寻常的竞赛正在进行，以确定一种能够限制疾病进展和严重程度的有效和安全的治疗方法。

著录项

来源
《The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology》 |2020年第7期|共7页
作者
Bruno Mégarbane; Jean-Michel Scherrmann;
展开▼
作者单位

Réanimation Médicale et Toxicologique H?pital Lariboisière 2 Rue Ambroise Paré 75010 Paris;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
azithromycin; COVID-19; hydroxychloroquine; risk/benefit; toxicity;

机译：氮霉素;Covid-19;羟基氯喹;风险/益处;毒性;

相似文献

外文文献
中文文献
专利

1. Electrocardiographic Safety of Daily Hydroxychloroquine 400 mg Plus Azithromycin 250 mg as an Ambulatory Treatment for COVID-19 Patients in Cameroon [J] . Liliane Mfeukeu-Kuate, William Djomo Ngatchou, Mazou Ngou Temgoua, 心血管病（英文） . 2021,第002期
2. IL-33 in COVID-19: friend or foe? [J] . Yuejin Liang, Yiyue Ge, Jiaren Sun 细胞与分子免疫学：英文版 . 2021,第006期
3. Accurate and sensitive determination of hydroxychloroquine sulfate used on COVID-19 patients in human urine,serum and saliva samples by GC-MS [J] . Süleyman Bodur, Sezin Erarpat, (O)mer Tahir Günkara, 药物分析学报（英文） . 2021,第003期
4. Azithromycin in patients with COVID-19: Friend or foe? [J] . Kow Chia Siang, Hasan Syed Shahzad Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2021,第1期

机译：患有Covid-19患者的阿奇霉素：朋友或敌人？
5. Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan [J] . Kazimieras Maneikis, Ugne Ringeleviciute, Justinas Bacevicius, IJC Heart & Vasculature . 2021,第4期

机译：使用心律失常风险管理计划减轻羟氯喹和阿奇霉素治疗的Covid-19患者的心律失常风险
6. Clinical outcomes and adverse events in patients hospitalised with COVID-19, treated with off-label hydroxychloroquine and azithromycin [J] . Kelly Mary, OConnor Roisin, Townsend Liam, British Journal of Clinical Pharmacology . 2021,第3期

机译：用Covid-19住院的患者的临床结果和不良事件，用Off-Label羟氯喹和阿奇霉素治疗
7. Friend or Foe: Studying user Trustworthiness for Friend Recommendation in the Era of Misinformation [C] . Antonela Tommasel 2019 IEEE Second International Conference on Artificial Intelligence and Knowledge Engineering . 2019

机译：朋友还是敌人：在错误信息时代，研究用户对朋友推荐的信任度
8. A Foe-Inspired Friend: Constructing a Tumor Tissue-Mimicking Biomaterial to Study Intratumoral Drug Transport [D] . Huayamares Moreno, Sebastian Gonzalo. 2020

机译：一个敌人灵感的朋友：构建肿瘤组织模拟生物材料以研究肿瘤内药物运输
9. Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan [O] . Kazimieras Maneikis, Ugne Ringeleviciute, Justinas Bacevicius, 2021

机译：使用心律失常风险管理计划减轻羟氯喹和阿奇霉素治疗的Covid-19患者的心律失常风险
10. Mitigating arrhythmia risk in Hydroxychloroquine and Azithromycin treated COVID-19 patients using arrhythmia risk management plan [O] . Kazimieras Maneikis, Ugne Ringeleviciute, Justinas Bacevicius, 2021

机译：使用心律失常风险管理计划减轻羟氯喹和阿奇霉素治疗的Covid-19患者的心律失常风险
11. Triggered Infrared Emitter Displays for Individual Identify Friend-or- Foe (IIFF) and Vehicular Mounted Identify Friend-or-Foe (VMIFF) Devices. [R] . Williams, P. S. 2007

机译：触发红外发射器显示器，用于识别敌人或敌人（IIFF）和车载识别敌人或敌人（VmIFF）设备。

Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

摘要

著录项

相似文献

相关主题

期刊订阅